Navigation Links
CuraGen to Present at the Bear Stearns 20th Annual Healthcare Conference
Date:9/5/2007

BRANFORD, Conn., Sept. 5 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN), a clinical-stage biopharmaceutical company focused on oncology, announced today that Dr. Frank M. Armstrong, President and Chief Executive Officer, will present an update on the Company at the Bear Stearns 20th Annual Healthcare Conference on Tuesday, September 11, 2007, at 11:00 a.m. Eastern time. The conference is being held at The Grand Hyatt New York in New York City on September 10-11, 2007.

Access to a live webcast of the presentation and the accompanying slides will be available from the Investor Relations section of CuraGen's website at http://www.curagen.com . A replay of the webcast will be available after the presentation and archived for 30 days thereafter.

About CuraGen

CuraGen Corporation (Nasdaq: CRGN) is a dedicated clinical-stage biopharmaceutical company developing diverse approaches, including novel protein, antibody, antibody-drug conjugate and small molecule therapeutics for the treatment of cancer and for cancer supportive care. CuraGen is currently conducting clinical trials to investigate the potential of velafermin, belinostat and CR011-vcMMAE. By leveraging the drug development strengths cultivated over the years, CuraGen expects to make a difference by advancing its promising therapeutics to address the unmet medical needs of cancer patients. CuraGen Corporation is headquartered in Branford, Connecticut. For additional information please visit http://www.curagen.com .

CuraGen Contact:

Glenn Schulman, Pharm.D.

Director of Investor Relations

gschulman@curagen.com

(888) 436-6642

CRGN-G


'/>"/>
SOURCE CuraGen Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
2. Researchers Present Ways To Reduce The Risk Of Dementia
3. Researchers Present Data Regarding The Efficiency Of Herbs
4. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
5. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
6. Drug Reactions First Present Themselves In The Mouth
7. Reminiscing Into The Past Makes You Dissatisfied With The Present
8. Living In The Past Indicates Dissatisfaction With Present
9. Movies Represent Coma In A Wrong Way
10. Onchocerciasis: Presentation And Treatment
11. Researchers Warn That Routine Physical Examination Could Miss Breech Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... Levels of a protein in ... to a study appearing online in the journal Radiology. , Heart disease and brain ... significantly due to the rapidly aging population. Damage to both organs often occurs at ...
(Date:12/7/2016)... Arbor, MI (PRWEB) , ... December 07, 2016 ... ... insurance and financial consultation services from offices located in South Lyon, Dewitt, Williamston, ... to benefit a basketball coach who needs treatment for a brain tumor. , ...
(Date:12/7/2016)... ... 07, 2016 , ... AlignLife clinics nationwide are giving back to their communities ... to receive bountiful gifts wrapped tightly under a Christmas Tree. AlignLife hopes to ... the world. , In exchange for generous donations, customers will receive a gift in ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... proud to announce that its fully redesigned website, which launched October 17, 2016, ... a sleek responsive design and easy-to-navigate layout. Visitors and patients can discover the ...
(Date:12/7/2016)... ... December 07, 2016 , ... 1105 Media’s Live From ... Folio: Marketing Awards competition. Live From won in the Use of Social Media ... ultimately successful projects undertaken by the media industry’s most innovative marketing professionals. ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)...   Arena Pharmaceuticals, Inc. (NASDAQ: ... in the ralinepag phase 2 trial.  Ralinepag is an ... for the treatment of pulmonary arterial hypertension (PAH). The ... "This marks an important step in the development ... on our pipeline," said Amit Munshi , Arena,s ...
(Date:12/7/2016)... Pharmacy, Inc. (NYSE: DPLO) has launched Diplomat Specialty Infusion Group, a ... BioRx, MedPro Rx, and XAS Infusion Suites. To learn ... ... Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.) ... continue to build on the work we have done, we are ...
(Date:12/7/2016)... PARK, Kan. , Dec. 7, 2016   Rx ... of West Virginia and its Public Employees Insurance ... plan members access to their innovative healthcare software, ultimately saving ... partner with PEIA and provide its members with access to ... changes or a more effective, affordable therapy can be found," ...
Breaking Medicine Technology: